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Objective: To evaluate the frequency and patterns of dyslipidemia in overweight and obese 
children and to determine the extent of blood lipid abnormality in overweight and obese 
children.
Methods: A prospective matched case control study on 230 overweight and obese children and 
adolescents (body mass index [BMI]  85th percentile) aged 4 to 18 years undertaken at the 
outpatient endocrine clinic of the Childrens’ Hospital at Tabriz University between 2006–2008. 
This study was conducted to compare the frequency of abnormal plasma lipid levels in overweight 
and obese children compared with 50 nonobese children (BMI = 50th–85th percentile).
Results: The total frequency of dyslipidemia was 69.58%. The prevalence of dyslipidemia 
increased with severity of obesity and reached 76.9% in the severely obese (P  0.005). High 
triglycerides was the most common dyslipidemia in combination (26.08%) and in isolation 
(18.6%). There was a significant difference in mean of triglycerides between the severely obese 
and other groups (P  0.004).
Conclusion: In the present study, dyslipidemia is more common in severely obese children 
and the most common component of dyslipidemia is a high triglyceride level.
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Introduction
Obesity is increasing in both children and adults in many countries around the 
world.1–4 A paradox of childhood underweight/overweight exists among children and 
adolescents living in Asian countries. However, the global problem of childhood 
obesity increasingly extends into the developing world. In Thailand, the prevalence 
of obesity among schoolchildren aged 6–12 years rose from 12.2% to 15.6% in just 
two years.5 In Japan, the prevalence of obesity among schoolchildren aged 6–14 years 
increased from 5% to 10% between 1974 and 1993.6 In Iran the prevalence of over-
weight youths aged 6–18 years doubled from 4.2% to 8.3% between 1993 and 1999.7 
Associated with the epidemic of obesity in young people is an epidemic of medical 
complications such as dyslipidemia, hypertension, and type 2 diabetes mellitus. One 
morbidity associated with obesity is cardiovascular disease which is invariably 
related to dyslipidemia.8 It is now well established that the atherosclerotic process 
and cardiovascular disease begins in youth and is significantly related to lipid 
abnormalities.9–11 The dyslipidemia associated with obesity is characterized by a triad 
of lipid abnormalities, including elevated serum triglycerides (TG), the presence of 
small, dense low-density lipoprotein (LDL) particles and reduced serum high-density 
lipoprotein cholesterol (HDL-C) levels.12 Pathologic studies, such as the Bogalusa Heart Therapeutics and Clinical Risk Management 2009:5 740
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Study, and the pathological determination of atherosclerosis 
in youth (PDAY) study, have shown that higher levels 
of LDL-cholesterol (LDL-C) are significantly related to 
increased areas of the aorta and coronary arteries involved 
with fatty streaks and fibrous plaques.13 The early detection 
of dyslipidemia in obese children and adolescents may help 
to delay or prevent chronic complications. In this regard the 
aim of the present study was to evaluate the frequency and 
patterns of dyslipidemia in obese children and adolescents 
and to determine the extent of blood lipid abnormality in 
overweight and obese children.
Patients and methods
study population
A matched case control study was conducted on overweight 
and obese children and adolescents, who were referred to 
the Children’s Hospital in Tabriz, Iran, from September 
2006 through to October 2008.
We investigated a sample of 230 overweight and obese 
children and adolescents. Patients were selected according to 
the following inclusion criteria: aged between 4 to 18 years 
and a body mass index (BMI) exceeding the 85th percentile 
for their age and sex.
exclusion criteria
Patients with familial hyperlipidemia, obesity secondary 
to genetic disorders, hypothyroidism, and who were using 
medication that alters lipid metabolism, were excluded.
Fifty nonobese children were recruited as a comparison 
control group. These patients were clinically evaluated by 
a physician. The following inclusion criteria were used for 
the control group: BMI 50th–85th percentile and absence 
of chronic diseases (liver, renal, thyroid). Patients in the 
control groups were age- and sex-matched with more than 
one patient. The local ethical committee approved the study 
and informed consent was obtained from the patients.
Anthropometric and metabolic variables
Demographic variables examined were age and sex. 
Anthropometric variables included weight, height, and BMI. 
To standardize BMI levels, conversion to a BMI Z-score 
was performed based on the Centers for Disease Control 
and Prevention growth charts.14 The case subjects were then 
classified as overweight (a Z-score of 1 to 2), moderately 
obese (a Z-score of 2 to 2.5), and severely obese (a Z-score 
above 2.5). Metabolic parameters were total cholesterol (TC), 
TG, HDL-C, and LDL-C.
Biochemical analysis
Blood samples were obtained after a 12-hour overnight fast 
for measurement of TC, HDL-C, LDL-C, and TGs. Lipid 
levels were measured with the use of an autoanalyzer (model 
200–747; Hitachi, Dubai, Saudi Arabia). Dyslipidemia was 
defined if the fasting plasma HDL-C was less than the 5th 
percentile or TGs, LDL-C, and TC were greater than the 95th 
percentile for age and sex.15
statistical analysis
Data was expressed as mean ± standard deviation (SD) num-
ber percentage. These were analyzed with the independent 
samples t-test, analysis of variance, Tukey’s test and Kendall’s 
tau-b correlation coefficient for TC, LDL, HDL, and TG 
between groups.
A P value less than 0.05 was considered statistically 
significant. The Statistics Package for Social Sciences 
(version 16; SPSS Inc., Chicago, IL, USA) was used for 
statistical analysis.
Results
Of 230 (94 male and 136 female) overweight and obese 
children and adolescents included in this study, 117 (50.9%) 
were severely obese, 41 (17.8%) were moderately obese, 
and 72 (31.3%) were overweight. With regard to their ages, 
43 (18.7%) of cases were of school age, 98 (42.6%) were 
preadolescent, and 89 (38.7%) were adolescents.
The mean values of age, weight, height, and BMI is 
provided in Table 1. BMI was statistically different between 
the overweight and obesity groups, compared to the control 
group (P  0.005). Table 2 shows the comparison of 
mean ± SD for lipid values by degree of obesity and sex. There 
was a significant difference for means of triglycerides between 
the severely obese and other groups (P  0.004). LDL-C in 
the severely obese group was significantly higher than in the 
normal group (P  0.005). There was a significant difference 
of mean HDL-C and TC between the overweight and obese 
groups compared to the control group (P  0.005).
The overall incidence of dyslipidemia was 69.58% 
(n = 160), 56.8% (n = 90) in the severely obese, 16.9% 
(n = 27) in the moderately obese, and 26.2% (n = 42) in the 
overweight. No one in the control group had dyslipidemia. 
According to the age incidence of dyslipidemia, there was 
62.8% (n = 27) of school age, 73.5% (n = 72) preadoles-
cents, and 67.4% (n = 60) in adolescents, but no statistical 
difference was observed. The prevalence of the dyslipidemia 
increased significantly as the BMI increased (P  0.005, 
df = 5, χ2 = 86.48).Therapeutics and Clinical Risk Management 2009:5 741
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There was a positive correlation (r = 0.226; P  0.0001) 
between BMI and triglycerides and a negative correlation 
(r = 0.255; P  0.0001) between BMI and HDL-C, with 
a significant correlation found between BMI and LDL-C 
(r = 0.96; P = 0.05).
Table 3 shows that the most common component of dys-
lipidemia in combination (26.08%) and in isolation (18.6%) 
was high TGs. Low HDL-C was the second component of 
lipid abnormality, whereas the combination of high TG and 
low HDL-C was observed in 8.3% of participants. All four 
components of the disorder were found in 3.5% of partici-
pants (n = 8). No statistical difference was observed within 
the groups according to sex and age.
Discussion
The findings in this study reveal a high prevalence of 
dyslipidemia in overweight and obese children and adolescents, 
regardless of age and sex. Approximately 50% of severe 
obese children and third of overweight children have dyslip-
idemia, which is higher than the overall youth population of 
the Bogalusa Heart Study.10 The combination of obesity and 
dyslipidemia has an additive effect of increasing the severity 
of atherosclerotic lesions in young people.16 Elevated LDL-C 
and BMI levels are also predictive of carodid intima-media 
thickness in adolescents, which is strongly associated with 
coronary atherosclerosis and cardiovascular risk. The rate 
of dyslipidemia according to our criteria was greater than 
the rate reported by Cook and colleagues,17 but the results 
of our analyses are consistent with reports by Gillian and 
colleagues.18 The degree of obesity in children and adoles-
cents has important clinical implications because the risk of 
death from all causes among adults with severe obesity is 
twice that than among moderately obese adults.19 Our study 
shows that, as with obese adults, high TG is the most common 
component. Moreover the mean TG concentration rises with 
increasing obesity (P  0.004) which is consistent with the 
findings of Lima and colleagues.20
The second component of the lipid abnormality was 
related to decreased levels of HDL-C. Hepatic triglyceride 
lipase catabolizes the TGs, resulting in a reduction in HDL 
particle size and an increase in HDL-C clearance, which 
leads a decrease in HDL-C levels. Many epidemiologic 
studies have demonstrated that low HDL-C levels are an 
independent risk factor for cardiovascular disease.18 HDL-C, 
which acts as protective factor against heart disease,21 showed 
borderline values in our study children, with slightly higher 
Table 1 General characteristics of the overweight, obese, and control groups
General 
characteristics
Severe obesity  Moderate obesity  Overweight  Control 
Male  
(n = 55)
Female 
(n = 62)
Male 
(n = 12)
Female 
(n = 29)
Male 
(n = 27)
Female 
(n = 45)
Male 
(n = 29)
Female 
(n = 21)
Age (years) 10.2 ± 3.2 8.4 ± 3.0 11.8 ± 2.5 10.9 ± 3.1 12.3 ± 2.0 11.2 ± 2.4 109. ± 4.1 10.3 ± 4.8
Weight (kg) 65.7 ± 23.5 53.7 ± 20.1 61.6 ± 11.1 56.7 ± 17.7 54.7 ± 11.2 51.0 ± 12.0 36.0 ± 13.0 34.2 ± 15.1
height (cm) 143.0 ± 18.2 133.5 ± 14.7 148.5 ± 15.2 142.1 ± 12.4 147.8 ± 11.9 143.3 ± 10.2 138.8 ± 17.1 134.3 ± 21.6
BMi (kg/m2) 30.9 ± 5.5 29.1 ± 5.7 27.2 ± 2.7 27.9 ± 4.2 24.7 ± 1.9 24.4 ± 2.5 17.8 ± 2.7 17.8 ± 3.0
Note: Mean ± standard deviation.
Abbreviation: BMi, body mass index.
Table 2 Lipid profile of the children and adolescents of the obesity, overweight, and control groups
Lipid profile Severely obese Moderately obese Overweight Control
Male 
(n = 55)
Female 
(n = 62)
Male  
(n = 12)
Female 
(n = 29)
Male  
(n = 27)
Female 
(n = 45)
Male  
(n = 29)
Female 
(n = 21)
Triglycerides 
(mg/dL)*
179.6 ± 30.7 183.1 ± 36.5 128.7 ± 67.1 107.8 ± 47.2 99.1 ± 34.5 105.6 ± 26.5 100.4 ± 11.1 102.0 ± 14.0
Total cholesterol 
(mg/dL)**
156.8 ± 92.6 144.5 ± 67.7 163.4 ± 31.7 190.1 ± 38.4 176.3 ± 24.3 183.8 ± 34.2 122.4 ± 11.3 123.0 ± 10.6
LDL-C (mg/dL)** 111.5 ± 34.4 113.0 ± 34.1 95.8 ± 25.3 118.6 ± 38.9 46.1 ± 8.9 42.8 ± 9.8 95.9 ± 9.5 96.8 ± 6.2
hDL-C (mg/dL)** 41.6 ± 10.8 45.0 ± 12.0 39.1 ± 6.2 45.2 ± 14.9 104.4 ± 24.1 114.2 ± 0.8 54.0 ± 7.2 54.2 ± 7.0
Notes: Mean ± standard deviation; *mg/dL × 0.01125 = nmol/L; **mg/dL × 0.02586 = nmol/L.
Abbreviations: hDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.Therapeutics and Clinical Risk Management 2009:5 742
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levels than those found by Webber and colleagues22 and Lima 
and colleagues.20 We found 14 children and adolescents 
with HDL-C  5th percentile for age and sex. There was a 
significant difference for mean HDL-C in the control group 
compared with the other groups.
LDL-C levels in our study were higher than those found 
by Moura and colleagues,23 which may be attributed to a 
high intake of saturated fat and to a low intake of dietary 
fiber.24
The third component of lipid abnormalities was related 
to increased levels of total cholesterol. There was significant 
difference between the mean of serum total cholesterol 
concentration in the normal group with other the groups 
(P  0.005). Our report is the first to describe the prevalence 
of dyslipidemia in overweight and obese children in northwest 
Iran. A limitation of this study is the possibility of selection 
bias because the study sample was based on patients who 
were referred to a weight management clinic. Children at 
increased risk may be more likely to be referred to a weight 
management program.
Conclusion
Our study demonstrated that the dyslipidemia is more 
common in severely obese children and adolescents, and 
high TGs was the most common component of dyslipidemia. 
We found a significant correlation between the elevation of 
TGs and the severity of obesity.
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